Hepatic Encephalopathy
Hepatic encephalopathy is a condition for which rifaximin is used. Rifaximin is supplied as a tablet in 200 mg, 400 mg and 550 mg strengths. The same medicine is also used for traveller’s diarrhoea.
Medicine used to treat Hepatic Encephalopathy
Key points
- Rifaximin is used in hepatic encephalopathy.
- Rifaximin tablets are available in 200 mg, 400 mg and 550 mg strengths.
- Rifaximin is also used in traveller’s diarrhoea.
Rifaximin and hepatic encephalopathy
Rifaximin is used for hepatic encephalopathy. It is taken as a tablet. See Rifaximin tablets for the product and strengths. The rifaximin ingredient covers the ingredient. The ingredient name and the product name are the same. For the condition, see hepatic encephalopathy. The tablets come in 200 mg, 400 mg and 550 mg strengths. Related products are grouped under digestive health. The strengths describe the tablets supplied; they are not a dose to take.
Traveller’s diarrhoea
Rifaximin is also used for traveller’s diarrhoea. This is a separate condition from hepatic encephalopathy. The tablet strengths are the same for both uses. Both uses are for the tablet form. Someone checking the ingredient can use the rifaximin ingredient. Rifaximin tablets is the product for both uses.
Tablet form and supply
Rifaximin is supplied as a tablet. The available strengths are 200 mg, 400 mg and 550 mg. Pharmacy partners in India ship orders to Malaysia in discreet packaging.
When to get advice
If you have hepatic encephalopathy, speak with your doctor about whether rifaximin is suitable for you. A doctor will decide whether the medicine is appropriate and how it should be used. Do not start, stop or change a medicine without medical advice. If you have traveller’s diarrhoea and are unsure whether rifaximin is appropriate, speak with your doctor. If you are unsure which strength you have, check the pack or ask your doctor or pharmacist. Keep medicines out of reach of children.
About hepatic encephalopathy
Hepatic encephalopathy has symptoms, causes and treatment. General information on these aspects is available from liver-health organisations.
Further reading
Last updated
